Geoff Meacham
Stock Analyst at B of A Securities
(3.72)
# 649
Out of 4,826 analysts
238
Total ratings
53.38%
Success rate
4.36%
Average return
Main Sectors:
Stocks Rated by Geoff Meacham
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NMRA Neumora Therapeutics | Downgrades: Underperform | $7 → $1 | $0.71 | +41.84% | 3 | Apr 2, 2025 | |
| MRNA Moderna | Initiates: Neutral | $40 | $27.84 | +43.68% | 10 | Mar 13, 2025 | |
| KYMR Kymera Therapeutics | Initiates: Buy | $52 | $33.63 | +54.62% | 4 | Mar 13, 2025 | |
| KNSA Kiniksa Pharmaceuticals International, | Initiates: Buy | $40 | $27.79 | +43.94% | 3 | Mar 13, 2025 | |
| BNTX BioNTech SE | Initiates: Buy | $145 | $101.10 | +43.42% | 1 | Mar 13, 2025 | |
| RNA Avidity Biosciences | Initiates: Buy | $70 | $32.28 | +116.85% | 4 | Mar 13, 2025 | |
| APGE Apogee Therapeutics | Initiates: Buy | $95 | $39.42 | +140.99% | 2 | Mar 13, 2025 | |
| ETNB 89bio | Initiates: Buy | $25 | $8.61 | +190.36% | 1 | Mar 13, 2025 | |
| BMRN BioMarin Pharmaceutical | Maintains: Buy | $99 → $103 | $62.06 | +65.97% | 3 | Feb 20, 2025 | |
| BIIB Biogen | Maintains: Neutral | $160 → $145 | $121.80 | +19.05% | 14 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $205 → $215 | $196.07 | +9.65% | 16 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $795 → $750 | $603.58 | +24.26% | 20 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $310 → $295 | $279.80 | +5.43% | 11 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $98 → $85 | $37.62 | +125.94% | 2 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $112 → $4 | $1.69 | +136.69% | 5 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $42 → $45 | $38.14 | +17.99% | 5 | Nov 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $125 | $102.81 | +21.58% | 6 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $575 | $500.19 | +14.96% | 4 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $1,150 → $1,100 | $821.46 | +33.91% | 9 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $6 → $1 | $0.44 | +127.53% | 3 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $22 → $31 | $10.50 | +195.24% | 2 | Oct 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $10 | $0.35 | +2,720.87% | 2 | Aug 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $145 | $82.84 | +75.04% | 6 | Jul 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $180 → $170 | $155.00 | +9.68% | 3 | Apr 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $38 | $32.99 | +15.19% | 2 | Apr 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $48 | $29.79 | +61.13% | 2 | Mar 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $68 → $60 | $50.06 | +19.86% | 8 | Jan 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $8 | $1.39 | +475.54% | 2 | Dec 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $23 → $14 | $6.15 | +127.64% | 2 | Sep 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $10 → $8 | $3.48 | +130.22% | 4 | Aug 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $17 | $1.08 | +1,474.07% | 1 | Aug 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $14 | $1.05 | +1,233.33% | 3 | Jul 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $50 → $45 | $23.88 | +88.44% | 6 | Apr 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $50 | $5.16 | +868.99% | 1 | Jan 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $24 | $1.86 | +1,193.80% | 4 | Nov 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $12 → $4 | $6.81 | -41.26% | 2 | Jun 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $1.46 | +1,817.81% | 1 | Aug 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $34 | $0.56 | +5,945.52% | 1 | Jul 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $56 | $4.26 | +1,214.55% | 3 | May 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $35 | $1.05 | +3,233.33% | 4 | Jan 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $525 | $3.04 | +17,169.74% | 1 | Nov 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $42 | $0.95 | +4,317.33% | 1 | Oct 20, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $20 | $6.44 | +210.80% | 1 | Sep 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $20 | $0.72 | +2,677.78% | 2 | Sep 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Underperform | $9 | $3.07 | +193.16% | 1 | Jun 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $60 | $9.80 | +512.24% | 1 | Jun 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underperform | $7 | $4.53 | +54.53% | 1 | Jun 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $15 → $23 | $12.85 | +78.99% | 3 | Aug 5, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $90 → $82 | $62.11 | +32.02% | 9 | May 3, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $100 → $95 | $298.70 | -68.20% | 6 | Mar 1, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $300 → $80 | $9.25 | +764.86% | 3 | Dec 20, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $43 → $40 | $40.78 | -1.91% | 7 | Nov 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $100 → $135 | $109.75 | +23.01% | 2 | Aug 1, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $8.08 | - | 4 | May 21, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $16 → $20 | $0.93 | +2,055.87% | 4 | May 3, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | n/a | $22.60 | - | 2 | Apr 5, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $127 → $158 | $273.55 | -42.24% | 5 | Nov 8, 2017 |
Neumora Therapeutics
Apr 2, 2025
Downgrades: Underperform
Price Target: $7 → $1
Current: $0.71
Upside: +41.84%
Moderna
Mar 13, 2025
Initiates: Neutral
Price Target: $40
Current: $27.84
Upside: +43.68%
Kymera Therapeutics
Mar 13, 2025
Initiates: Buy
Price Target: $52
Current: $33.63
Upside: +54.62%
Kiniksa Pharmaceuticals International,
Mar 13, 2025
Initiates: Buy
Price Target: $40
Current: $27.79
Upside: +43.94%
BioNTech SE
Mar 13, 2025
Initiates: Buy
Price Target: $145
Current: $101.10
Upside: +43.42%
Avidity Biosciences
Mar 13, 2025
Initiates: Buy
Price Target: $70
Current: $32.28
Upside: +116.85%
Apogee Therapeutics
Mar 13, 2025
Initiates: Buy
Price Target: $95
Current: $39.42
Upside: +140.99%
89bio
Mar 13, 2025
Initiates: Buy
Price Target: $25
Current: $8.61
Upside: +190.36%
BioMarin Pharmaceutical
Feb 20, 2025
Maintains: Buy
Price Target: $99 → $103
Current: $62.06
Upside: +65.97%
Biogen
Feb 13, 2025
Maintains: Neutral
Price Target: $160 → $145
Current: $121.80
Upside: +19.05%
Feb 3, 2025
Maintains: Buy
Price Target: $205 → $215
Current: $196.07
Upside: +9.65%
Jan 28, 2025
Maintains: Neutral
Price Target: $795 → $750
Current: $603.58
Upside: +24.26%
Jan 28, 2025
Maintains: Neutral
Price Target: $310 → $295
Current: $279.80
Upside: +5.43%
Jan 7, 2025
Maintains: Buy
Price Target: $98 → $85
Current: $37.62
Upside: +125.94%
Jan 7, 2025
Downgrades: Underperform
Price Target: $112 → $4
Current: $1.69
Upside: +136.69%
Nov 25, 2024
Maintains: Buy
Price Target: $42 → $45
Current: $38.14
Upside: +17.99%
Nov 14, 2024
Initiates: Buy
Price Target: $125
Current: $102.81
Upside: +21.58%
Nov 14, 2024
Initiates: Buy
Price Target: $575
Current: $500.19
Upside: +14.96%
Oct 31, 2024
Maintains: Buy
Price Target: $1,150 → $1,100
Current: $821.46
Upside: +33.91%
Oct 30, 2024
Downgrades: Underperform
Price Target: $6 → $1
Current: $0.44
Upside: +127.53%
Oct 18, 2024
Upgrades: Buy
Price Target: $22 → $31
Current: $10.50
Upside: +195.24%
Aug 19, 2024
Maintains: Buy
Price Target: $12 → $10
Current: $0.35
Upside: +2,720.87%
Jul 31, 2024
Maintains: Buy
Price Target: $150 → $145
Current: $82.84
Upside: +75.04%
Apr 17, 2024
Maintains: Neutral
Price Target: $180 → $170
Current: $155.00
Upside: +9.68%
Apr 12, 2024
Maintains: Buy
Price Target: $40 → $38
Current: $32.99
Upside: +15.19%
Mar 13, 2024
Maintains: Buy
Price Target: $24 → $48
Current: $29.79
Upside: +61.13%
Jan 3, 2024
Downgrades: Neutral
Price Target: $68 → $60
Current: $50.06
Upside: +19.86%
Dec 15, 2023
Downgrades: Neutral
Price Target: $8
Current: $1.39
Upside: +475.54%
Sep 8, 2023
Downgrades: Neutral
Price Target: $23 → $14
Current: $6.15
Upside: +127.64%
Aug 21, 2023
Maintains: Underperform
Price Target: $10 → $8
Current: $3.48
Upside: +130.22%
Aug 21, 2023
Maintains: Buy
Price Target: $19 → $17
Current: $1.08
Upside: +1,474.07%
Jul 20, 2023
Reinstates: Buy
Price Target: $14
Current: $1.05
Upside: +1,233.33%
Apr 21, 2023
Maintains: Neutral
Price Target: $50 → $45
Current: $23.88
Upside: +88.44%
Jan 5, 2023
Initiates: Buy
Price Target: $50
Current: $5.16
Upside: +868.99%
Nov 1, 2022
Downgrades: Underperform
Price Target: $24
Current: $1.86
Upside: +1,193.80%
Jun 8, 2022
Downgrades: Neutral
Price Target: $12 → $4
Current: $6.81
Upside: -41.26%
Aug 10, 2021
Initiates: Buy
Price Target: $28
Current: $1.46
Upside: +1,817.81%
Jul 13, 2021
Initiates: Buy
Price Target: $34
Current: $0.56
Upside: +5,945.52%
May 7, 2021
Upgrades: Buy
Price Target: $56
Current: $4.26
Upside: +1,214.55%
Jan 15, 2021
Downgrades: Neutral
Price Target: $35
Current: $1.05
Upside: +3,233.33%
Nov 23, 2020
Initiates: Buy
Price Target: $525
Current: $3.04
Upside: +17,169.74%
Oct 20, 2020
Initiates: Buy
Price Target: $42
Current: $0.95
Upside: +4,317.33%
Sep 15, 2020
Reinstates: Buy
Price Target: $20
Current: $6.44
Upside: +210.80%
Sep 8, 2020
Reinstates: Buy
Price Target: $20
Current: $0.72
Upside: +2,677.78%
Jun 25, 2020
Reinstates: Underperform
Price Target: $9
Current: $3.07
Upside: +193.16%
Jun 25, 2020
Reinstates: Buy
Price Target: $60
Current: $9.80
Upside: +512.24%
Jun 25, 2020
Initiates: Underperform
Price Target: $7
Current: $4.53
Upside: +54.53%
Aug 5, 2019
Maintains: Equal-Weight
Price Target: $15 → $23
Current: $12.85
Upside: +78.99%
May 3, 2019
Downgrades: Equal-Weight
Price Target: $90 → $82
Current: $62.11
Upside: +32.02%
Mar 1, 2019
Maintains: Underweight
Price Target: $100 → $95
Current: $298.70
Upside: -68.20%
Dec 20, 2018
Downgrades: Equal-Weight
Price Target: $300 → $80
Current: $9.25
Upside: +764.86%
Nov 6, 2018
Maintains: Equal-Weight
Price Target: $43 → $40
Current: $40.78
Upside: -1.91%
Aug 1, 2018
Maintains: Overweight
Price Target: $100 → $135
Current: $109.75
Upside: +23.01%
May 21, 2018
Downgrades: Underweight
Price Target: n/a
Current: $8.08
Upside: -
May 3, 2018
Maintains: Equal-Weight
Price Target: $16 → $20
Current: $0.93
Upside: +2,055.87%
Apr 5, 2018
Downgrades: Equal-Weight
Price Target: n/a
Current: $22.60
Upside: -
Nov 8, 2017
Maintains: Overweight
Price Target: $127 → $158
Current: $273.55
Upside: -42.24%